Background: There have been still few objective outcome measures regarding the effect of botulinum toxin type A treatment. Tensiomyography (TMG) is used as a device that can non-invasively evaluate skeletal muscle, however, no reports have been found that the effects of botulinum toxin type A treatment have been evaluated by the characteristics of muscle contraction using TMG.

Objective: To evaluate the clinical usefulness of quantitative assessment using TMG before and after injection of botulinum toxin type A in patients after stroke.

Read more HERE!